Sponsor intelligence · OTHER
Clinical trials sponsored by
Institute Of Hematology & Blood Diseases Hospital, China.
Real, source-linked trial activity for Institute Of Hematology & Blood Diseases Hospital, China: 10 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 19, 2026. Source-linked, daily-refreshed.
PHASE1 3NA 2PHASE2 2PHASE4 1N/A 1PHASE1/PHASE2 1
Newest Institute Of Hematology & Blood Diseases Hospital, China trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 2d ago | Liposomal Mitoxantrone Plus Azacitidine and Venetoclax in Newly Diagno | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 9d ago | Phase 1 Study of F182112 in Relapsed/Refractory Autoimmune Hemolytic A | Ph 1 | NOT_YET_RECRUITING | ↗ |
| 24d ago | A Study of Bometase Alfa for Bleeding Control in Acquired Hemophilia A | NA | NOT_YET_RECRUITING | ↗ |
| 25d ago | Multi-target Drugs Sequential Combination Therapy in Adults Patients W | Ph 4 | RECRUITING | ↗ |
| 25d ago | A Study of Elranatamab for Inhibitor Eradication in Patients With Hemo | NA | NOT_YET_RECRUITING | ↗ |
| 26d ago | A Clinical Study of HY035 Cell Injection in the Treatment of CD7-posit | Ph 1 | ENROLLING_BY_INVITATION | ↗ |
| 41d ago | A Randomized Phase II Selection Trial of Venetoclax-Based Induction In | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 44d ago | BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloid | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 44d ago | Plasma ctDNA Monitoring in Pediatric Acute Leukemia | N/A | NOT_YET_RECRUITING | ↗ |
| 58d ago | SHR2554 Plus Liposomal Mitoxantrone as First-line Treatment for Periph | Ph 1/Ph 2 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Institute Of Hematology & Blood Diseases Hospital, China (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.